Published in Biomaterials on October 11, 2013
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier. Pharmaceutics (2014) 0.83
Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B (2016) 0.79
Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer. Theranostics (2016) 0.78
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget (2016) 0.78
Designing polymers with sugar-based advantages for bioactive delivery applications. J Control Release (2015) 0.77
Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases. AAPS J (2015) 0.77
Insulin-Based Regulation of Glucose-functionalized Nanoparticle Uptake in Muscle Cells. J Mater Chem B Mater Biol Med (2014) 0.75
Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles. Int J Nanomedicine (2015) 0.75
Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy. Int J Nanomed Nanosurg (2016) 0.75
Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.75
Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy. Front Pharmacol (2016) 0.75
Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions. Physiol Rep (2017) 0.75
Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats. Oncotarget (2016) 0.75
Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate. PLoS One (2017) 0.75
Engineering the RNA-Nanobio Interface. Bioengineering (Basel) (2017) 0.75
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain. Nat Commun (2017) 0.75
GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update. Nucleic Acids Res (2007) 2.22
Visible-light-enhanced catalytic oxidation reactions on plasmonic silver nanostructures. Nat Chem (2011) 1.90
Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm (2009) 1.32
Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review. PLoS One (2013) 1.22
Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int J Pharm (2006) 1.21
Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.14
Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials (2011) 1.11
Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Int J Pharm (2010) 1.11
Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci (2005) 1.03
Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials (2011) 1.01
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials (2012) 1.00
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.00
Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation. Int J Nanomedicine (2013) 0.99
The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials (2011) 0.98
The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study. J Cancer Res Clin Oncol (2012) 0.95
A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population. Arch Toxicol (2013) 0.95
Transbuccal delivery of 2',3'-dideoxycytidine: in vitro permeation study and histological investigation. Int J Pharm (2002) 0.94
Catalytic and photocatalytic transformations on metal nanoparticles with targeted geometric and plasmonic properties. Acc Chem Res (2013) 0.94
Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer. Int J Pharm (2013) 0.93
Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. Eur J Pharm Biopharm (2010) 0.93
Enhanced transfection of polyplexes based on pluronic-polypropylenimine dendrimer for gene transfer. Arch Pharm Res (2009) 0.92
Singular characteristics and unique chemical bond activation mechanisms of photocatalytic reactions on plasmonic nanostructures. Nat Mater (2012) 0.92
The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles. Biomaterials (2011) 0.92
Solid tumor penetration by integrin-mediated pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel. Biomaterials (2012) 0.91
Clinical perspective of afatinib in non-small cell lung cancer. Lung Cancer (2013) 0.91
PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Int J Pharm (2011) 0.89
Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles. Arch Pharm Res (2008) 0.89
Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors. Biomaterials (2012) 0.88
A practical approach for determination of mass spectral baselines. J Am Soc Mass Spectrom (2011) 0.88
Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Biomaterials (2011) 0.88
Simulation of triacylglycerol ion profiles: bioinformatics for interpretation of triacylglycerol biosynthesis. J Lipid Res (2013) 0.87
Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel. Biomaterials (2013) 0.85
Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation. Int J Nanomedicine (2012) 0.85
Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105/L101 mixed polymeric micelles. Yakugaku Zasshi (2008) 0.84
MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met. Cell Physiol Biochem (2014) 0.83
Oral absorption of ginsenoside Rb1 using in vitro and in vivo models. Planta Med (2006) 0.83
Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation. Int J Nanomedicine (2013) 0.83
Mature cystic teratoma of the fallopian tube associated with incomplete uterine mediastinum: A case report and literature review. Oncol Lett (2013) 0.82
In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. Eur J Pharm Biopharm (2013) 0.82
Perifosine enhances mTORC1-targeted cancer therapy by activation of GSK3β in NSCLC cells. Cancer Biol Ther (2012) 0.82
Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs. Int J Pharm (2004) 0.82
Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. J Control Release (2012) 0.82
Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation. Int J Pharm (2011) 0.81
Polycation nanostructured lipid carrier, a novel nonviral vector constructed with triolein for efficient gene delivery. Biochem Biophys Res Commun (2008) 0.81
A coumarin-based fluorescent probe for biological thiols and its application for living cell imaging. Org Biomol Chem (2013) 0.80
Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation. Int J Pharm (2010) 0.80
Differentiation of rat iPS cells and ES cells into granulosa cell-like cells in vitro. Acta Biochim Biophys Sin (Shanghai) (2013) 0.80
Effect of phospholipid composition on pharmacokinetics and biodistribution of epirubicin liposomes. J Liposome Res (2011) 0.80
Hypoxia-inducible factor-1α polymorphisms and risk of cancer metastasis: a meta-analysis. PLoS One (2013) 0.80
Sixty-two cases of simple obesity treated by acupuncture combined with massage. J Tradit Chin Med (2004) 0.79
TNF-α-308 G>A polymorphism and colorectal cancer risk: a meta-analysis. Int J Colorectal Dis (2012) 0.79
A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons. Int J Pharm (2013) 0.79
Controlling catalytic selectivity on metal nanoparticles by direct photoexcitation of adsorbate-metal bonds. Nano Lett (2014) 0.78
A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Int J Pharm (2013) 0.78
Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation. AAPS PharmSciTech (2013) 0.78
Self-assembled carboxymethyl poly (L-histidine) coated poly (β-amino ester)/DNA complexes for gene transfection. Biomaterials (2011) 0.78